Study
TREM2 Deficiency Aggravates Neuroinflammation and Cognitive Impairment via Disease-Associated Microglia in Parkinson’s Disease Models
Microglial dysfunction linked to cognitive decline in Parkinson’s.
Summary
In plain language
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This research investigates how deficiency in TREM2, an immune receptor gene, worsens neuroinflammation and cognitive decline. The study provides insights into the role of microglial function in neurodegeneration and potential therapeutic targets for conditions like Alzheimer's disease.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
TREM2 Deficiency Aggravates Neuroinflammation and Cognitive Impairment via Disease-Associated Microglia in Parkinson’s Disease Models
Published October 2025
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored March 30, 2026 using rubric v8_2026-03-10.
Assessment
The study provides valuable insights into the role of TREM2 in neuroinflammation and cognitive decline, but its preclinical nature limits direct applicability to seniors. Methodological details are not fully accessible, affecting transparency and bias control assessment.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 5.0/10 | |
| Bias control | 3.3/10 | |
| Statistical methods | 5.0/10 | |
| Reporting completeness | 5.0/10 | |
| Conflicts & funding | 5.0/10 | |
| Replication | 5.0/10 | |
| Relevance to chosen population | 0.0/10 | |
| Journal Reliability | 10.0/10 |
Additional Notes
Further research in human populations is necessary to confirm these findings and their relevance to senior health.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.